Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
AlphaGenome is an API and Python toolkit developed by Google DeepMind, designed specifically for the field of computational genomics. It enables researchers to submit DNA sequences or genetic variants to receive predictions related to gene expression, RNA splicing, chromatin accessibility, transcription-factor interactions, histone modifications, and genomic interactions. The API also facilitates variant scoring and the analysis of genomic regions in both human and mouse datasets, complete with tutorials and reference materials to assist in creating programmatic workflows. This tool aids researchers in exploring how genetic alterations can influence gene regulation and assists in prioritizing research hypotheses for further investigation. Access is granted via a hosted API, supplemented by a Python package for local client-side implementation and various notebook examples for practical application. While AlphaGenome serves as a valuable resource for research purposes, it is important to note that it has not been validated or sanctioned for clinical or diagnostic applications, and its predictions should not be misconstrued as clinical findings. Additionally, the platform encourages collaboration among researchers by providing an interactive environment for data analysis.
Description
Pharmaceutical companies require extensive genomic data to effectively implement precision medicine initiatives; however, they frequently rely on merely 10% of the available information for their decisions. Genomenon provides access to the complete dataset. Their Prodigy™ Patient Landscapes offer a streamlined and economical solution for natural history research, aiding the creation of therapies for rare diseases by deepening understanding of both retrospective and prospective health data. Utilizing an advanced AI-driven methodology, Genomenon conducts a thorough evaluation of each patient documented in the medical literature in a significantly reduced timeframe. Ensure you capture all relevant insights by exploring every genomic biomarker featured in published studies. Each scientific claim is substantiated by concrete evidence drawn from the medical literature, allowing researchers to uncover all genetic drivers and identify variants recognized as pathogenic in accordance with ACMG clinical standards, thereby enhancing the development process of targeted therapies. By leveraging this comprehensive approach, pharma companies can enhance their research effectiveness and ultimately improve patient outcomes.
API Access
Has API
Yes
API Access
Has API
Yes
Integrations
Google Cloud Platform
Yes
Google Antigravity
Yes
Google Colab
Yes
Integrations
Google Cloud Platform
Yes
Google Antigravity
No
Google Colab
No
Pricing Details
Free for non-commercial research use, subject to terms. Commercial research access is in private preview; commercial and enterprise workflows are also offered through Google Cloud.
Free Trial
No
Free Version
Yes
Pricing Details
No price information available.
Free Trial
No
Free Version
No
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Customer Support
Business Hours
No
Live Rep (24/7)
No
Online Support
Yes
Customer Support
Business Hours
Yes
Live Rep (24/7)
No
Online Support
Yes
Types of Training
Training Docs
Yes
Webinars
No
Live Training (Online)
No
In Person
No
Types of Training
Training Docs
Yes
Webinars
Yes
Live Training (Online)
Yes
In Person
Yes
Vendor Details
Company Name
Google DeepMind
Founded
2010
Country
United Kingdom
Website
deepmind.google/science/alphagenome/
Vendor Details
Company Name
Genomenon
Country
United States
Website
www.genomenon.com/pharma/